Nimisha Srivastava|Innovative Research Award|Pharmaceutical Sciences

Published on by Network Science

Innovative Research Award

Nimisha Srivastava
Amity University · India

Nimisha Srivastava
Affiliation Amity University
Country India
Google Scholar ID f3P_5J8AAAAJ
Documents 71
Citations 570
h-index 12
Subject Area Pharmaceutical Sciences
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0002-6566-6335

Nimisha Srivastava recognizes research contributions that demonstrate originality, scholarly rigor, and potential value to scientific and professional communities. This academic recognition profile presents the supplied research information for Nimisha Srivastava of Amity University, India, whose stated subject area is pharmaceutical sciences. The profile also identifies the researcher in connection with the International Research Awards on Network Science & Graph Analytics. Research metrics are reported as supplied and should be checked against the researcher’s current public profiles before formal publication. [1] [2]

1. Abstract

This article provides an academic recognition profile for Nimisha Srivastava, affiliated with Amity University in India, with pharmaceutical sciences identified as the subject area. The supplied research indicators comprise 71 documents, 570 citations, and an h-index of 12. These indicators offer a quantitative snapshot of reported scholarly output and citation activity, but they do not independently establish the quality, originality, or practical significance of individual contributions. A detailed assessment of research topics, publication records, and documented outcomes would be needed to describe specific scientific achievements reliably. [1] [2]

2. Keywords

Innovative Research Award; Nimisha Srivastava; Amity University; India; pharmaceutical sciences; academic research; research impact; scholarly publications; citation metrics; research recognition; International Research Awards on Network Science & Graph Analytics.

3. Introduction

Academic awards provide a framework for recognizing research achievements, encouraging knowledge exchange, and highlighting work that may contribute to scientific advancement. In pharmaceutical sciences, research can encompass drug discovery, formulation development, pharmacology, pharmaceutical analysis, drug delivery, and related areas. The significance of any particular contribution depends on the research question, methodological quality, reproducibility, and relevance to the scientific or healthcare community.

The Innovative Research Award profile presented here summarizes the information supplied for Nimisha Srivastava. The event named in the profile is the International Research Awards on Network Science & Graph Analytics. The researcher’s stated subject area is pharmaceutical sciences; no specific connection between that discipline and network science or graph analytics is asserted without supporting evidence. The event’s official website provides the relevant organizational context. [3]

4. Research Profile

The information supplied identifies Nimisha Srivastava as a researcher affiliated with Amity University in India. Pharmaceutical sciences is listed as the subject area. A public researcher profile can help readers examine publication metadata, author attribution, citation activity, and scholarly outputs, provided that the profile is correctly matched to the individual. [1] [2]

The following information was provided for this article:

These details are presented as supplied rather than as independently verified measurements. Researcher metrics can change over time and may differ across databases because of coverage, citation matching, duplicate records, and profile maintenance. A current profile review is recommended before the figures are used in a formal award announcement. [1] [2]

5. Research Contributions

A comprehensive account of a researcher’s contributions normally considers published studies, the questions addressed, methods used, principal findings, and the influence of the work on subsequent research or professional practice. In pharmaceutical sciences, relevant contributions may include experimental studies, analytical methods, formulation strategies, drug-delivery technologies, pharmacological investigations, or reviews that synthesize existing evidence. These are general examples of the discipline and are not claims about the specific work of Nimisha Srivastava.

The supplied information does not include individual publication titles, abstracts, experimental findings, patents, clinical outcomes, or project descriptions. Accordingly, this profile does not attribute particular discoveries or inventions to the researcher. A publication-level review would provide the evidence needed to identify research themes and explain the originality, methodological strengths, and potential applications of specific contributions.

6. Publications

The supplied profile information reports 71 documents. This figure is presented as a reported total and should not be interpreted as a verified count of peer-reviewed journal articles alone. Bibliographic databases may include different document types, such as research articles, reviews, conference papers, and other indexed publications. The composition of the reported document total has not been provided. [1] [2]

For a complete publication record, individual entries should be checked against the researcher’s public scholarly profile and the publishers’ records. Where available, each entry should include the article title, author list, publication year, journal or conference, volume and page information, and DOI. No individual publications or DOI identifiers were supplied for this article, so no paper-specific citations are asserted.

7. Research Impact

The supplied bibliometric indicators are 570 citations and an h-index of 12. Citation counts measure recorded citations within a particular database and at a particular time. The h-index is a combined indicator of publication output and citation activity: an h-index of 12 generally means that at least 12 publications have each received at least 12 citations within the dataset and profile from which the value was calculated. The reported figure should be confirmed against the current source profile before publication. [1] [2]

Bibliometric measures can help describe research visibility, but they should not be used in isolation to evaluate scientific merit. Citation practices vary across disciplines, publication types, and career stages. A broader assessment may consider methodological rigor, reproducibility, research integrity, collaboration, practical relevance, and the contribution of individual studies to their fields.

8. Award Suitability

The Innovative Research Award provides a recognition framework for assessing research originality, scholarly contributions, and potential scientific or societal relevance. The information supplied for this profile identifies an institutional affiliation, a subject area, and bibliometric indicators that may serve as starting points for an award review. However, these details alone do not establish eligibility, demonstrate a specific innovative achievement, or confirm that an award has been granted.

A transparent evaluation process may consider the following evidence:

  • Originality and significance of the research question.
  • Quality, rigor, and reproducibility of the research methods.
  • Verified publication records and the researcher’s contribution to collaborative work.
  • Evidence of scholarly influence, appropriate to the discipline and career stage.
  • Documented scientific, technological, clinical, or societal relevance where applicable.
  • Compliance with the award’s published eligibility and assessment requirements.

The named event is the International Research Awards on Network Science & Graph Analytics. Readers should consult the official event website for the applicable award categories, nomination requirements, evaluation procedures, and current event information. [3] This article does not represent an official award decision or imply that the researcher has received an award.

9. Conclusion

Nimisha Srivastava’s supplied profile identifies Amity University in India as the institutional affiliation and pharmaceutical sciences as the subject area. The reported indicators are 71 documents, 570 citations, and an h-index of 12. These details provide a preliminary overview of the research profile but require verification against current scholarly records. A fuller account of research contributions and suitability for an award would require examination of individual publications, documented findings, and the relevant award criteria. The profile should therefore be understood as an informational academic summary rather than an independent assessment or confirmation of award status.

11. References

  1. Google Scholar. (n.d.). Author profile associated with the supplied Google Scholar identifier f3P_5J8AAAAJ. The profile is provided as a source for checking indexed publications and citation indicators; the current metrics and author attribution should be verified directly.https://scholar.google.com/citations?user=f3P_5J8AAAAJ&hl=en&oi=sra
  2. ORCID. (n.d.). ORCID record for the supplied identifier 0000-0002-6566-6335. ORCID provides persistent researcher identifiers that can help distinguish researchers and connect their scholarly contributions. The record should be checked to confirm the identity and associated works.https://orcid.org/0000-0002-6566-6335
  3. International Research Awards on Network Science & Graph Analytics. (n.d.). Official event website. Consult the event website for published information about the conference, award categories, nomination process, and applicable eligibility criteria.
    https://networkscience-conferences.researchw.com/

 Lomass Soliman | Young Researcher Award | Pharmaceutical Sciences

Published on by Network Science

Young Researcher Award

 Lomass Soliman
Affiliation Institute of Pharmaceutical Technology and Regulatory Affairs
Country Hungary
Scoholar ID 6osAAAAJ
Documents 5
Citations 23
h-index 3
Subject Area Pharmaceutical Sciences
Event International Research Awards on Network Science & Graph Analytics

Lomass Soliman
Institute of Pharmaceutical technology and regulatory affairs

 Lomass Soliman The recognition is associated with the International Research Awards on Network Science & Graph Analytics and is intended to highlight emerging researchers whose scholarly activities demonstrate developing expertise, research engagement, and potential for continued contribution to their discipline.

Abstract

This academic recognition profile presents Lomass Soliman in the context of the Young Researcher Award. Soliman is affiliated with the Institute of Pharmaceutical Technology and Regulatory Affairs at the University of Szeged in Hungary and works within the broad field of pharmaceutical sciences. The supplied scholarly indicators record five documents, 23 citations, and an h-index of 3. These metrics describe an emerging publication and citation record and may be considered alongside the quality, originality, relevance, and documented contribution of individual research outputs. Bibliometric indicators are generally most informative when interpreted together with qualitative evidence of scholarly contribution rather than as standalone measures of research quality. [2]

Keywords

  • Lomass Soliman
  • Young Researcher Award
  • Pharmaceutical Sciences
  • Pharmaceutical Technology
  • Regulatory Affairs
  • University of Szeged
  • Research Recognition
  • Bibliometric Indicators

Introduction

Young researcher recognition generally emphasizes the development of an independent scholarly profile, research productivity, methodological competence, and potential for sustained contribution. Within pharmaceutical sciences, research may encompass drug development, pharmaceutical formulation, delivery systems, analytical methods, manufacturing technologies, quality considerations, and regulatory frameworks. The Institute of Pharmaceutical Technology and Regulatory Affairs at the University of Szeged provides an academic setting relevant to these interdisciplinary areas.

Evaluation of early-career researchers benefits from combining quantitative measures with qualitative assessment. Publication counts and citation indicators can provide useful evidence of scholarly visibility, while peer-reviewed research, methodological rigor, originality, reproducibility, and relevance offer additional dimensions for evaluation. [1]

Research Profile

Lomass Soliman’s supplied academic information places the researcher within Pharmaceutical Sciences, with an institutional affiliation in pharmaceutical technology and regulatory affairs. The available Google Scholar identifier is BPP-6osAAAAJ, while the supplied bibliometric record reports five documents, 23 citations, and an h-index of 3. [3]

The combination of pharmaceutical technology and regulatory affairs represents an interdisciplinary research environment in which scientific development can intersect with formulation, product quality, evaluation, and regulatory considerations. Further assessment of the research profile would appropriately consider the specific topics, study designs, venues, and contribution statements associated with the documented publications.

Research Contributions

Based on the supplied information, Soliman’s research profile is situated within pharmaceutical sciences and the institutional domain of pharmaceutical technology and regulatory affairs. The available record supports recognition of an emerging scholarly trajectory rather than a definitive assessment of a specific research breakthrough. Detailed contribution analysis should examine the originality, scientific methodology, reproducibility, and practical or regulatory relevance of individual publications.

  • Development of scholarly activity within pharmaceutical sciences.
  • Engagement with research at the intersection of pharmaceutical technology and regulatory affairs.
  • Establishment of an emerging citation and publication record.
  • Potential for continued interdisciplinary research and professional development.

Publications

The supplied profile reports five scholarly documents associated with the researcher. Individual publication titles, journals, publication years, authorship positions, and DOI identifiers were not provided in the source information supplied for this page. Consequently, specific publications and DOI records should be verified against authoritative bibliographic databases before being added to a formal publication list. This approach avoids attributing publications or identifiers without adequate source verification.

Research Impact

The supplied metrics indicate 23 citations across five documents and an h-index of 3. Citation counts can provide an indication of scholarly uptake, but their interpretation depends on field, publication age, document type, collaboration patterns, and database coverage. [2] For a young researcher, these indicators may be considered as part of a broader assessment that includes research quality, contribution to collaborative projects, methodological development, and prospects for future work.

Award Suitability

Lomass Soliman’s supplied academic profile is consistent with the general concept of a Young Researcher Award because it documents active scholarly work in Pharmaceutical Sciences and an identifiable record of publications and citations. The affiliation with the University of Szeged further establishes an academic research context. Final award eligibility and selection, however, should be determined according to the official criteria of the International Research Awards on Network Science & Graph Analytics and through the event’s formal review process.

Relevant evaluation may include the quality and originality of publications, demonstrated research contribution, academic progression, scholarly visibility, and the potential for continued impact. The current bibliometric indicators can serve as supporting evidence but should not substitute for peer or committee assessment.

Conclusion

Lomass Soliman represents an emerging researcher in Pharmaceutical Sciences affiliated with the University of Szeged in Hungary. The supplied record of five documents, 23 citations, and an h-index of 3 provides a measurable foundation for evaluating early scholarly development.

Within the Young Researcher Award context, the profile may be considered alongside publication quality, research originality, contribution, and future potential. Further bibliographic verification and review of individual research outputs would strengthen a comprehensive assessment.

References

  1. International Committee of Medical Journal Editors. (n.d.). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals.https://www.icmje.org/recommendations/
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.https://doi.org/10.1073/pnas.0507655102
  3. Google Scholar. (n.d.). Google Scholar profile: Lomass Soliman, profile ID BPP-6osAAAAJ.https://scholar.google.com/citations?hl=en&user=BPP-6osAAAAJ
  4. University of Szeged. (n.d.). Institute of Pharmaceutical Technology and Regulatory Affairs.https://www.u-szeged.hu/

Azar Tahghighi | Molecular Docking & Molecular Dynamic | Research Excellence Award

Published on by Network Science

Research Excellence Award

Azar Tahghighi
Pastur Institute of Iran
Azar Tahghighi
Affiliation Pastur Institute of Iran
Country Iran
Scopus ID 24923832500
Documents 47
Citations 728
h-index 15
Subject Area Molecular Docking & Molecular Dynamic
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0002-1221-4490

Azar Tahghighi is a researcher affiliated with the Pastur Institute of Iran whose scholarly activities span molecular docking, molecular dynamics simulations, medicinal chemistry, antimicrobial discovery, and computational drug design. Her body of work integrates in silico methodologies with experimental validation to investigate biologically active compounds, receptor-ligand interactions, and novel therapeutic candidates. Through contributions to peer-reviewed scientific literature, she has participated in advancing contemporary approaches for drug discovery and biological target identification.[1]

Abstract

This article summarizes the academic achievements and research contributions of Azar Tahghighi in the fields of medicinal chemistry and computational molecular sciences. Her research portfolio emphasizes molecular docking, molecular dynamics, pharmacophore modeling, antimicrobial agent discovery, and receptor-targeted therapeutic development. By combining computational prediction with laboratory validation, her work contributes to the identification of biologically relevant compounds and supports contemporary drug discovery strategies.[2]

Keywords

Molecular Docking, Molecular Dynamics, Medicinal Chemistry, Drug Discovery, TLR7 Ligands, Pharmacophore Modeling, Antibacterial Agents, Antibiofilm Activity, Computational Biology, Virtual Screening.

Introduction

Modern pharmaceutical research increasingly relies on computational techniques to accelerate therapeutic discovery and optimize candidate selection. Azar Tahghighi’s research aligns with this interdisciplinary trend by integrating computational chemistry, structural biology, and medicinal chemistry approaches. Her studies frequently investigate molecular interactions and biological pathways relevant to infectious diseases, immune modulation, and antimicrobial resistance.[3]

Research Profile

According to available scholarly metrics, the researcher has produced 47 indexed documents, accumulated 728 citations, and achieved an h-index of 15. Her scientific activities encompass molecular docking, molecular dynamic simulations, synthetic medicinal chemistry, receptor-targeted drug design, and antimicrobial evaluation. These contributions reflect sustained engagement with computational and experimental biomedical research.[1]

Research Contributions

  • Development of novel triazoloquinoxaline derivatives targeting Toll-like receptor 7.
  • Application of pharmacophore-based virtual screening and molecular docking techniques.
  • Investigation of antibacterial and antibiofilm compounds against resistant pathogens.
  • Research on probiotic-derived antibacterial extracts and microbial control strategies.
  • Evaluation of green chemistry approaches for antifungal drug synthesis.

Publications

  • Structure-guided design of triazolo[4,3-a] quinoxaline-4-ol derivatives as novel TLR7 ligands (2026).
  • Identification of new triazoloquinoxaline amine derivatives against Toll-like receptor 7 (2025).
  • Antibacterial and Antibiofilm Efficacy against MRSA (2025).
  • Click chemistry for green synthesis of antifungal medications (2024).
  • Anti-bacterial and anti-biofilm activity of probiotic Lactobacillus extracts (2024).

Research Impact

The research output demonstrates the practical application of computational methodologies for identifying promising therapeutic candidates. Publications addressing immune receptor modulation, antimicrobial resistance, and medicinal chemistry contribute to scientific understanding in areas of ongoing biomedical importance. Citation performance further indicates that her work has received recognition within relevant academic communities.[4]

Award Suitability

Azar Tahghighi’s multidisciplinary research profile demonstrates sustained scholarly productivity, measurable citation impact, and active engagement in computational and experimental biomedical sciences. Her contributions to molecular modeling, medicinal chemistry, and antimicrobial research align with the principles of research excellence recognized by international scientific award programs. The combination of publication quality, innovation, and translational relevance supports consideration for academic recognition.[5]

Conclusion

Azar Tahghighi has established a research portfolio focused on computational drug discovery, medicinal chemistry, and antimicrobial innovation. Through a combination of molecular modeling techniques and laboratory-based investigations, her work contributes to advancing therapeutic development and biological target evaluation. These accomplishments reflect a meaningful contribution to contemporary biomedical research and scientific scholarship.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Azar Tahghighi, Author ID 24923832500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24923832500
  2. Chemical Physics Impact. (2026). Structure-guided design of triazolo[4,3-a] quinoxaline-4-ol derivatives as novel TLR7 ligands.
    https://doi.org/10.1016/j.chphi.2026.101045
  3. PLOS One. (2025). Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7.
    https://doi.org/10.1371/journal.pone.0336701
  4. Journal of Medical Microbiology and Infectious Diseases. (2025). Antibacterial and Antibiofilm Efficacy of a Synthetic Nitrofuranyl Pyranopyrimidinone Derivative.
    https://doi.org/10.61882/JoMMID.13.2.139
  5. Chemical Biology & Drug Design. (2024). Click chemistry beyond metal-catalyzed cycloaddition as a tool for antifungal medication synthesis.
    https://doi.org/10.1111/cbdd.14555
  6. Iranian Biomedical Journal. (2024). Evaluation of Anti-Bacterial and Anti-Biofilm Activity of Native Probiotic Strains of Lactobacillus Extracts.
    https://doi.org/10.61186/ibj.4043